- Correction
- Open access
- Published:
Correction: A methylation‑ and immune‑related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
Journal of Ovarian Research volume 17, Article number: 112 (2024)
Correction: J Ovarian Res 16, 186 (2023)
Following publication of the original article [1], an error was spotted in Fig. 4a where the x-axis should say ‘time (months)’ rather than ‘time (mouths)’. The correct images were shown below.
Incorrect figure:

Correct figure:

The original article has been corrected.
Reference
Chen L, Gao W, Lin L, et al. A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance. J Ovarian Res. 2023;16:186. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13048-023-01260-9.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Chen, L., Gao, W., Lin, L. et al. Correction: A methylation‑ and immune‑related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance. J Ovarian Res 17, 112 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13048-024-01438-9
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13048-024-01438-9